Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 17Lymphoma 12Leukemia 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Non-Hodgkin 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Hodgkin Disease 4Myelodysplastic Syndromes 3Multiple Myeloma 3Leukemia, Myeloid, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hematologic Neoplasms 3Graft vs Host Disease 3Waldenstrom Macroglobulinemia 2Myelodysplastic-Myeloproliferative Diseases 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Carcinoma, Renal Cell 2Stomach Neoplasms 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Myeloproliferative Disorders 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 23Cyclosporine 17Busulfan 16fludarabine phosphate 14Radiotherapy 12Mycophenolic Acid 12Cord Blood Stem Cell Transplantation 12Antilymphocyte Serum 12Peripheral Blood Stem Cell Transplantation 11Whole-Body Irradiation 10Methotrexate 8Methylprednisolone 7Tacrolimus 6Filgrastim 6Melphalan 5fludarabine 4sargramostim 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Cytarabine 3Cyclosporins 3merphos 2Transplantation 2Thiotepa 2Thalidomide 2Arsenic Trioxide 2vatalanib 1paricalcitol 1lintuzumab 1gamma-Globulins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anemia, Refractory × Pentostatin × Clear all
NCT00045305 2023-06-28

Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

Eastern Cooperative Oncology Group

Phase 2 Completed
17 enrolled 10 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡